Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome

被引:59
|
作者
Worthington, Judith E.
McEwen, Anna
McWilliam, Lorna J.
Picton, Michael L.
Martin, Susan
机构
[1] Manchester Royal Infirm, Transplantat Lab, Manchester Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
[2] Manchester Royal Infirm, Dept Histopathol, Manchester M13 9WL, Lancs, England
[3] Manchester Royal Infirm, Dept Renal Med, Manchester M13 9WL, Lancs, England
关键词
C4d staining; HLA-specific antibodies; renal transplant outcome;
D O I
10.1097/01.tp.0000251430.11723.b6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. We carried out a retrospective study of C4d staining in paraffin sections from renal transplant biopsies to determine the association between C4d staining, donor-specific antibodies (DSA), histological features, and graft outcome. Methods. We studied 92 patients who had been biopsied for graft dysfunction. Biopsies were classified using Banff 97 criteria and features suggestive of antibody-mediated rejection were noted. Paraffin sections were stained with a polyclonal antibody using an immunoperoxidase technique. The presence of DSA in concurrent sera was determined by enzyme-linked immunosorbent assay and clinical data were reviewed. Results. Of the 92 cases, 15% showed diffuse and 24% showed focal C4d positivity. The grafts failed in 36% of the diffuse (P < 0.025), 23% of the focal, and 7% of the negative group at between one month and 15 years posttransplantation. Only patients in the group with diffuse C4d positivity had concurrent DSA (five cases, P < 0.001). Of the five DSA-positive patients, three had type 11 acute rejection and two of these transplants subsequently failed. The remaining two had chronic allograft nephropathy with features of alloimmune injury. Only two of the nine DSA-negafive/C4d-positive transplants had failed at the time of writing, in one case due to recurrent disease. Conclusion. We demonstrated a significant association between diffuse C4d staining, production of DSA, and graft failure. Although the concurrent detection of DSA and C4d positivity is uncommon in our patients, these results indicate that outcome in this group is poor and they may benefit from therapies directed at the humoral response.
引用
收藏
页码:398 / 403
页数:6
相关论文
共 50 条
  • [41] The relevance of complement C4d staining in renal allograft biopsies
    Khairwa, Anju
    INDIAN JOURNAL OF TRANSPLANTATION, 2020, 14 (02) : 94 - 98
  • [42] Association between Donor-Specific HLA Antibodies and Adverse Outcome Following Paediatric Cardiac Transplantation
    Irving, C.
    Hasan, A.
    Carter, V.
    Gennery, A.
    Parry, G.
    Kirk, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S232 - S233
  • [43] Donor-specific antibodies: Can they predict C4d deposition in pediatric heart recipients?
    Peng, David M.
    Law, Yuk M.
    Kemna, Mariska S.
    Warner, Paul
    Nelson, Karen
    Boucek, Robert J.
    PEDIATRIC TRANSPLANTATION, 2013, 17 (05) : 429 - 435
  • [44] Impact of C1q fixing donor-specific antibodies on renal transplant outcome
    Baranwal, Ajay Kumar
    Goswami, Sanjeev
    Agarwal, Sanjay Kumar
    Kaur, Gurvinder
    Mehra, Narinder Kumar
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 94 (01)
  • [45] Influence of preformed donor-specific antibodies and C4d on early liver allograft function
    Perera, M. T.
    Silva, M. A.
    Murphy, N.
    Briggs, D.
    Mirza, D. F.
    Neil, D. A. H.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (12) : 1444 - 1451
  • [46] Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies
    Haller, Jana
    Wehmeier, Caroline
    Honger, Gideon
    Hirt-Minkowski, Patricia
    Gurke, Lorenz
    Wolff, Thomas
    Steiger, Juerg
    Amico, Patrizia
    Dickenmann, Michael
    Schaub, Stefan
    TRANSPLANTATION, 2019, 103 (09) : E273 - E280
  • [47] Differential impact of delayed graft function in deceased donor renal transplant recipients with and without donor-specific HLA-antibodies
    Haller, Jana
    Wehmeier, Caroline
    Honger, Gideon
    Hirt-Minkowski, Patricia
    Gurke, Lorenz
    Wolff, Thomas
    Steiger, Jurg
    Amico, Patrizia
    Dickenmann, Michael
    Schaub, Stefan
    SWISS MEDICAL WEEKLY, 2018, 148 : 4S - 5S
  • [48] Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
    DeVos, Jennifer M.
    Gaber, A. Osama
    Knight, Richard J.
    Land, Geoffrey A.
    Suki, Wadi N.
    Gaber, Lillian W.
    Patel, Samir J.
    KIDNEY INTERNATIONAL, 2012, 82 (05) : 598 - 604
  • [49] The Influence of HLA Class II Donor-Specific Antibodies Present at the Time of Renal Transplantation on Early Graft Outcome
    Bryan, C.
    Gupta, A.
    Murillo, D.
    Wang, C.
    Yarlagadda, S.
    Nawabi, A.
    Schmitt, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 326 - 326
  • [50] OUTCOMES, DONOR-SPECIFIC ANTIBODIES AND C4d IMMUNOSTAINING IN PATIENTS DEVELOPING POST-TRANSPLANT PLASMA CELL HEPATITIS
    Ozturk, Begum
    Fiel, M. Isabel
    Schiano, Thomas D.
    HEPATOLOGY, 2021, 74 : 896A - 896A